• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

ZEG Berlin GmbH

Zentrum für Epidemiologie und Gesundheitsforschung

  • Home
  • Expertise
    • Real-World Evidence
    • Non-interventional study design
    • Post-authorization safety studies
    • Post-authorization efficacy studies
    • Cohort studies
    • Case-control studies
    • Medical Devices
    • Data collection instruments
  • Services
    • RWE Services
    • Crisis Management
    • Consulting
    • Data Management and Biostatistics
    • Medical Writing
    • Study Management
    • Quality Assurance
    • Pharmacovigilance
  • Library & News
    • News/Conferences
    • Publications
  • PROs
    • Menopause Rating Scale
      • Menopause Rating Scale (MRS) – Languages
    • Aging Male Symptoms Scale
      • AMS – properties as an outcome measure
      • AMS – properties as a screening tool
    • Quality of Sexual Function Scale
      • Quality of Sexual Function Scale
    • Short Term Hormone Effect Scale
      • Short Term Hormone Effect Scale
    • Research team
  • About Us
    • Who We Are
      • Management Board
      • Executive Team
      • Project Management Team
    • History
    • Careers
    • Data Protection Information
  • Contact

Management Board

Klaas Heinemann

Klaas Heinemann

Managing Director

Klaas Heinemann leads ZEG Berlin in providing data of quality and integrity to pharmaceutical companies.  Klaas sets the organization’s overall direction for its work in pharmacoepidemiology and drug safety.Read More

Clare Barnett

Director, Project Management & Chief Operating Officer

Clare Barnett oversees the implementation of ZEG Berlin’s global study portfolio, bringing with her a decade of experience working in pharmacoepidemiology and drug safety.Read More

Marc Pignot

Chief Strategy Officer, Head of Real-World Evidence & Safety Data Analytics

Dr. Marc Pignot joined ZEG Berlin to lead the implementation and development of Real-World Evidence & Safety Data Analytics. As Chief Strategy Officer, he is establishing a strong secondary data stream to complement and combine with ZEG Berlin’s long-established primary data business. Read More

Karl Pauls

Director of Pharmacovigilance

Karl is responsible for organizing drug safety reporting within the studies and acts as senior medical consultant for internal and external stakeholders.Read More

Johanna Poppe

Chief of Staff, Office Manager

Johanna Poppe coordinates human resources within ZEG Berlin and with external HR and oversees the organization and coordination of office operations and procedures to ensure organizational effectiveness and efficiency.Read More

sidebar

Who We Are

  • Executive Team
  • Management Board
  • Project Management Team

To All Diagnostic Tools

About Us

  • Data Protection Information
    • Business partners
    • Job applicants
    • Study participants
      • Datenschutzrichtlinie
      • Partecipanti allo Studio
      • Política de privacidad
      • Studiedeltagare
      • Uczestnicy badania
      • політика конфіденційності
  • Who We Are
    • Executive Team
    • Management Board
    • Project Management Team
  • History
  • Careers

To All Diagnostic Tools

Executive Team

  • Clare Barnett
  • Karl Pauls
  • Michael Schultze
  • Alfred Pauls
  • Do Minh Thai
  • Elisabeth Finger
  • Jens A. Lange
  • Antje Simon

Management Board

  • Klaas Heinemann
  • Clare Barnett
  • Marc Pignot
  • Karl Pauls
  • Johanna Poppe

Project Management Team

  • Pauline De Corte
  • Lisa Eggebrecht
  • Mohammed Dagher
  • Ulrike Amann-Gassner
  • Armin Papkalla
  • Silke Zimmermann
  • Nik Kolb

Search

Expertise

  • Non-interventional study design
  • Post-authorization safety studies
  • Post-authorization efficacy studies
  • Cohort studies
  • Case-control studies
  • Medical Devices
  • Patient Reported Outcomes (PROs)
    • Aging Male Symptoms Scale
    • Menopause Rating Scale
    • Scale for Quality of Sexual Function
    • Short Term Hormone Effect Scale
    • Research team
  • Data collection instruments

sidebar-alt

Footer

ZEG Berlin

Berlin Center for Epidemiology and Health Research

Invalidenstraße 115
10115 Berlin
Germany

Contact Us

Expertise

  • Real-World Evidence
  • Non-interventional study design
  • Post-authorization safety studies
  • Post-authorization efficacy studies
  • Cohort studies
  • Case-control studies
  • Medical Devices
  • Patient Reported Outcomes (PROs)
  • Data collection instruments

Services

  • Crisis Management
  • Consulting
  • Data Management and Biostatistics
  • Medical Writing
  • Study Management
  • Quality Assurance
  • Pharmacovigilance

ENCePP

We are a partner centre of the ENCePP scientific network which is coordinated by the European Medicines Agency. We are dedicated to excellence in research by adhering to the ENCePP Guide on Methodological Standards and promoting scientific independence and transparency. We register studies in the ENCePP E-Register of Studies, a publicly accessible resource for the registration of pharmacoepidemiological and pharmacovigilance studies.

General Data Protection Regulation

With a view to the introduction of the GDPR/EUDSGVO we are glad to present our newupdated privacy policy . The updated description are stored under “about us” and then “privacy policy/GDPR”. Further translation for study participants will follow contemporary.

© 2011–2025 ZEG Berlin

Impressum

Website by Laura Yeffeth.